Dual antiplatelet therapy with aspirin and an oral P2Y12 inhibitor is indicated for at least 12 months as the default strategy in patients with ACS who are not at high bleeding risk. Several ...
The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an ...
PHILADELPHIA, PA / ACCESS Newswire / November 3, 2025 / Prolocor, Inc., a healthcare startup developing the innovative diagnostic Prolocor pFCG TM test that identifies patients at higher and lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback